The compounding pharmacy responsible for a deadly fungal meningitis outbreak in 2012 has finalized a plan to compensate families. Moldy steroid injections from the New England Compounding Center are blamed for sickening 153 Tennesseans and killing 16 people in the state.
Health problems linger from a fungal meningitis outbreak that sickened hundreds across the country a year ago. Some people are still receiving treatment. And some who got better relapsed for reasons that aren’t entirely clear.
Victims of last year’s fungal meningitis outbreak – first spotted in Tennessee – are filing lawsuits nearly every day ahead of an October 1st cutoff. Most of them are counting on a consumer protection law passed by the state legislature in the late 1970s.
There are new reports of illness related to injected steroids, this time traced back to a compounding pharmacy in Tennessee. An outbreak that originated with the New England Compounding Center in Massachusetts last year sickened hundreds and killed 55 people, including 15 Tennesseans.
Before 2012, few knew the first thing about fungal meningitis – even doctors. And compounding pharmacies flew well under most people’s radar. That changed as moldy spinal injections sickened hundreds across the country.
People who received tainted steroid injections aren’t in the clear just yet, according to Tennessee’s Health Commissioner. His comments come as health officials are seeing new types of infections linked to the shots
More often a critic of federal regulation, Congressman Marsha Blackburn is asking why the Food and Drug Administration didn’t do more under existing rules.
The New England Compounding Center – blamed for the nationwide outbreak of fungal meningitis – has surrendered its license to operate in Tennessee. At least four other states have already suspended the pharmacy’s license.
The outbreak of fungal meningitis continues to widen from its epicenter in Tennessee, with a dozen deaths nationwide. At-risk patients who’ve gotten tested are finding some relief in negative results.